Login | Register

Sector: Pharmaceuticals

BOTOX v PROTOX: Australia’s highest court issues its decision
BOTOX v PROTOX: Australia’s highest court issues its decision

The decision will likely increase the difficulties faced by trademark owners wishing to deter other traders from referencing their trademarks.

Retailers hit hard as economic conditions return to volatility: WTR Brand Elite analysis
Retailers hit hard as economic conditions return to volatility: WTR Brand Elite analysis

Stock markets returned to volatility in February. In contrast to January, when major indices rose in value, key markets fell last month.

Pharmaceuticals correspondent

Thought leadership from industry experts
Latest content

“The quality of the names is crucial”: Novartis’ top tips for pharma branding success

David Lossignol, head of the pharma legal brand IP team at Novartis, reveals how he managed to juggle the 2019 INTA presidency alongside increasing duties at the company, to earn his operation the WTR Healthcare and Life Sciences Team of the Year Award.

23 December 2020

Preparation and collaboration: the cornerstones of any successful brand strategy

Carnot Laboratorios general counsel Antonio Donatlán Herrera reveals how his team handled the IP intricacies of a multinational brand launch in an industry where the threat of counterfeits is a threat to human health.

22 December 2020

WTR Brand Elite analysis: November 2020

Featured in Stock market performance

The WTR Brand Elite project tracks how a defined set of brand-focused companies with industry-leading trademark teams perform against stock market indices.

17 December 2020

Double examination of trademark applications: National Trademark Office develops worrying new practice

A new practice initiated by Colombia’s National Trademark Office is causing concern in the trademark community, as second-instance decisions - which, according to the law, cannot be subject to further legal remedies - are no longer the final decisions in the administrative process.

09 December 2020

‘.io’ Policy no BETR for complainant

This case shows that, even though the bad-faith requirements of the ‘.io’ Policy are more relaxed than those of the UDRP, the standard of proof of each alleged bad-faith argument under the ‘.io’ Policy is no lower.

07 December 2020

Amazon v InfoHealth and the reality of David versus Goliath trademark cases

In late November UK media reports seized on allegations of trademark bullying on the part of Amazon. However, this guest post argues that the situation was more nuanced than reported.

03 December 2020

Good news for Allergan as General Court confirms genuine use of JUVEDERM ULTRA in Class 5

This decision of the EU General Court in revocation proceedings serves as a reminder that trademark applicants must proceed with caution and ensure that the description of the goods/services corresponds to the intended use of the mark.

02 December 2020

BrewDog trademark dispute regret; CJEU rejects wine bottle; Clarivate acquires Hanlim IPS – news digest

In our latest round-up, we look at spoon-bender Uri Geller giving his permission to use a Pokemon after a two-decade dispute, Spin Master signing a licensing deal with Warner Bros, and much more.

01 December 2020

Rhymes but not a crime: BOTOX v PROTOX

In a blow to pharmaceutical company Allergan, the Federal Court of Australia has concluded that the use of PROTOX and BOTOX in composite phrases for skincare products did not infringe Allergan's prior BOTOX marks.

25 November 2020

WTR Brand Elite analysis: October 2020

Featured in Stock market performance

The WTR Brand Elite indices registered a two-point drop in the month ending 30 September – their first fall in seven months. The latest results returned a similar decline.

23 November 2020

Unlock unlimited access to all WTR content

Subscribe Now